Shree Ganesh Biotech (India) Ltd - Revised Un-Audited Financial Result Quarter Ending 30Th June, 2022 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday July 25, 2022 at the Registered Office of the Company and transacted the following business. Note: Due to typo error and erratum find herewith revised Un-Audited Financial Result quarter ending 30th June, 2022 pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015. Thanking You,